Skip to main content
TipRanks
Go Ultimate75% OFF

Boundless Bio Inc. (BOLD) Financial Statements

54 Followers

Boundless Bio Inc. Financial Overview

Boundless Bio Inc.'s market cap is currently $58.08M. The company's EPS TTM is $-2.47; its P/E ratio is -1.01; Boundless Bio Inc. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ -1.25M$ -1.09M$ 0.00$ 0.00$ 0.00
Operating Income$ -63.55M$ -73.27M$ -54.80M$ -46.47M$ -25.30M
EBITDA$ -56.95M$ -64.28M$ -48.48M$ -44.96M$ -24.53M
Net Income$ -58.20M$ -65.36M$ -49.43M$ -45.90M$ -25.21M
Balance Sheet
Cash & Short-Term Investments$ 107.58M$ 152.11M$ 120.75M$ 66.72M$ 73.03M
Total Assets$ 157.06M$ 206.41M$ 129.89M$ 76.83M$ 113.72M
Total Debt$ 49.03M$ 47.63M$ 2.19M$ 5.18M$ 377.00K
Net Debt$ 31.17M$ 21.05M$ -21.51M$ -5.77M$ -33.91M
Total Liabilities$ 58.41M$ 55.77M$ 256.98M$ 158.53M$ 151.91M
Stockholders' Equity$ 98.65M$ 150.64M$ -127.08M$ -81.70M$ -38.19M
Cash Flow
Free Cash Flow$ -47.21M$ -63.38M$ -47.49M$ -40.66M$ -25.28M
Operating Cash Flow$ -46.66M$ -60.84M$ -46.85M$ -39.60M$ -23.25M
Investing Cash Flow$ 37.80M$ -26.10M$ -38.26M$ 16.13M$ -59.28M
Financing Cash Flow$ 141.00K$ 89.82M$ 97.90M$ 126.00K$ 105.53M

Currency in USD

Boundless Bio Inc. Earnings and Revenue History

-150M-100M-50M00 %0.4 %0.8 %1.2 %EarningsProfit Margin2017201820212022202320242025RevenueEarningsProfit Margin

Boundless Bio Inc. Liabilities to Assets

0200M400M600M0 %80 %160 %240 %LiabilitiesLiabilities to Assets2017201820212022202320242025AssetsLiabilitiesLiabilities to Assets

Boundless Bio Inc. Cash Flow

-400M-200M0200M400M600M2017201820212022202320242025OperatingInvestingFinancing

Boundless Bio Inc. Forecast EPS vs Actual EPS

-1.2-1-0.7-0.5-0.20Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26EPS EstimateBeatMiss